The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B‐cell lymphoma

INTRODUCTION: For patients with diffuse large B‐cell lymphoma (DLBCL), standard‐care is rituximab administered with CHOP or CHOP‐like chemotherapy (R‐CHOP). However, the effectiveness and safety of R‐CHOP among DLBCL patients with human immunodeficiency virus (HIV) infection is less clear, as HIV+ p...

Descripción completa

Detalles Bibliográficos
Autores principales: Habbous, Steven, Guo, Helen, Beca, Jaclyn, Dai, Wei Fang, Isaranuwatchai, Wanrudee, Cheung, Matthew, Chan, Kelvin K. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541135/
https://www.ncbi.nlm.nih.gov/pubmed/32794362
http://dx.doi.org/10.1002/cam4.3362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541135/
https://www.ncbi.nlm.nih.gov/pubmed/32794362
http://dx.doi.org/10.1002/cam4.3362

Ejemplares similares